Logo
I

Immudicon

10 employees

Immudicon is a biotechnology company that creates complement-based biologics which targets and localizes immune cells to tumors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Immunology
Preclinical Research
Cancer Therapeutics
Immunoediting
Health Care

Date founded

2011

Funding rounds raised

I

Immudicon raised undisclosed on November 1, 2013

Investors: Dorm Room Fund

FAQ